Ophthalmogenetics and Gene Therapy

Ophthalmic hereditary qualities are worried over the acquired duty to ophthalmic disease, including assertion of models and dangers of legacy, and what's all the more finding, portrayal, and movement of medications for inborn assortments from the standard. The advances in quality treatment keep up wide assurance for the fix of ophthalmic conditions. Quality treatment is in addition in a circumstance to oversee basic open-edge glaucoma (POAG) in animal models, and research show it is monetarily practical. Characteristics may likewise be passed on into cells in vitro or in vivo using viral or non-viral vectors. Continuous particular advances have provoked the demonstration of the sub-nuclear reason of an extent of visual ailments. Genetic characteristics of Partial blindness Improvement.

  • Gene Therapy
  • Familial exudative vitreal retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy
  • Genetics of Myopia Development

 

 

  • Genetics of Myopia Development
  • Retinoblastoma

Related Conference of Ophthalmogenetics and Gene Therapy

March 18-19, 2024

5th World Congress on Ophthalmology and Vision Science

Zurich, Switzerland
April 25-26, 2024

24th Global Ophthalmologists Annual Meeting

London, UK
May 09-10, 2024

7th International Eye and Vision Congress

Barcelona, Spain
May 16-17, 2024

8th World Congress on Eye and Vision

Rome, Italy
June 13-14, 2024

9th International Conference on Eye and Vision

Barcelona, Spain
October 10-11, 2024

34th World Congress on Ophthalmology and Optometry

Madrid, Spain
October 10-11, 2024

10th Global Ophthalmology Meeting

Madrid, Spain

Ophthalmogenetics and Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in